Design Therapeutics annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Design Therapeutics Depreciation & Amortization Growth & History (DSGN)
Design Therapeutics's depreciation and amortization was $622,000 for fiscal 2025.
View full Design Therapeutics company overviewDesign Therapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $622,000 | $26,000 | +4.36% |
| 2024 | 2024-12-31 | $596,000 | $59,000 | +10.99% |
| 2023 | 2023-12-31 | $537,000 | $131,000 | +32.27% |
| 2022 | 2022-12-31 | $406,000 | $277,000 | +214.73% |
| 2021 | 2021-12-31 | $129,000 | $124,000 | +2480.00% |
| 2020 | 2020-12-31 | $5,000 | — | — |
Design Therapeutics quarterly depreciation and amortization
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $151,000 | −$1,000 | −0.66% |
| Q1 2026 | 2026-03-31 | $157,000 | −$2,000 | −1.26% |
| Q4 2025 | 2025-12-31 | $156,000 | — | — |
| Q3 2025 | 2025-09-30 | $155,000 | $2,000 | +1.31% |
| Q2 2025 | 2025-06-30 | $152,000 | $1,000 | +0.66% |
| Q1 2025 | 2025-03-31 | $159,000 | $16,000 | +11.19% |
| Q3 2024 | 2024-09-30 | $153,000 | $16,000 | +11.68% |
| Q2 2024 | 2024-06-30 | $151,000 | $18,000 | +13.53% |
| Q1 2024 | 2024-03-31 | $143,000 | $14,000 | +10.85% |
| Q3 2023 | 2023-09-30 | $137,000 | $29,000 | +26.85% |
| Q2 2023 | 2023-06-30 | $133,000 | $41,000 | +44.57% |
| Q1 2023 | 2023-03-31 | $129,000 | $47,000 | +57.32% |
| Q3 2022 | 2022-09-30 | $108,000 | $77,000 | +248.39% |
| Q2 2022 | 2022-06-30 | $92,000 | $80,000 | +666.67% |
| Q1 2022 | 2022-03-31 | $82,000 | $78,000 | +1950.00% |
| Q3 2021 | 2021-09-30 | $31,000 | — | — |
| Q2 2021 | 2021-06-30 | $12,000 | — | — |
| Q1 2021 | 2021-03-31 | $4,000 | — | — |
Design Therapeutics depreciation and amortization trends
Over the last five fiscal years, Design Therapeutics's depreciation and amortization increased from $5,000 to $622,000, a change of $617,000. The latest reported quarter, Q2 2026, shows $151,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Design Therapeutics source filings ↗